Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100171353 | 10017135 | 3 | F | 20110127 | 20140922 | 20140318 | 20140930 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-15518871 | BRISTOL MYERS SQUIBB | 65.00 | YR | M | Y | 0.00000 | 20140930 | N | CN | IN | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100171353 | 10017135 | 1 | PS | IPILIMUMAB | IPILIMUMAB | 1 | INTRAVENOUS | D | 0 | 221.7 | MG | INJECTION | |||||||
| 100171353 | 10017135 | 2 | C | TELMISARTAN. | TELMISARTAN | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 5 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 6 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 8 | C | INSULIN | INSULIN NOS | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 9 | C | GLYBURIDE. | GLYBURIDE | 1 | D | 0 | |||||||||||
| 100171353 | 10017135 | 10 | C | RANITIDINE | RANITIDINERANITIDINE HYDROCHLORIDE | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100171353 | 10017135 | 1 | Malignant melanoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100171353 | 10017135 | OT |
| 100171353 | 10017135 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100171353 | 10017135 | Malignant neoplasm progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100171353 | 10017135 | 1 | 20110120 | 20110207 | 0 | |
| 100171353 | 10017135 | 2 | 2008 | 20110204 | 0 | |
| 100171353 | 10017135 | 3 | 2008 | 20110127 | 0 | |
| 100171353 | 10017135 | 4 | 2004 | 20110127 | 0 | |
| 100171353 | 10017135 | 5 | 201006 | 20110203 | 0 | |
| 100171353 | 10017135 | 6 | 2008 | 20110127 | 0 | |
| 100171353 | 10017135 | 7 | 2008 | 20110203 | 0 | |
| 100171353 | 10017135 | 8 | 20110127 | 20110206 | 0 | |
| 100171353 | 10017135 | 9 | 20110127 | 20110127 | 0 | |
| 100171353 | 10017135 | 10 | 20110127 | 20110127 | 0 |